To Improve Worldwide Patient Safety 

The Uppsala Monitoring Centre (UMC) is an independent foundation and a centre for international service and scientific research.

Our priorities are the safety of patients and the safe and effective use of medicines in every part of the world.

We meet these priorities by innovative research and development, and by providing data, reference, consultative and training resources to medicines regulatory agencies, health professionals, researchers and the pharmaceutical industry all over the world. 

Our Vision is a world where all patients and health professionals make wise therapeutic decisions in their use of medicines.

Read the latest quarterly message from
Marie Lindquist

37th Annual Meeting of Representatives of the National Centres participating in the WHO Programme for International Drug Monitoring

The meeting took place on 14th to 17th October in Tianjin, China, hosted by the Chinese FDA, with over 50 national pharmacovigilance centres represented. A full report will appear in the January edition of Uppsala Reports.


30 October 2014

vigiRank, recently launched and tested by Uppsala Monitoring Centre (UMC), provides a method for detecting more plausible signals, with fewer false leads, th...

26 October 2014

In October, the WHO Programme for International Drug Monitoring passed the milestone of 10 million ICSRs (individual case safety reports) in the WHO Global I...

7 October 2014

Following extensive consultations involving the UK’s Thalidomide Trust, WHO and the Uppsala Monitoring Centre, experts have identified key actions to d...

Follow us:

Uppsala Monitoring Centre · Tel: +46 18 65 60 60 · Fax: +46 18 65 60 88

Privacy Policy · Cookies · Contact webmaster · Copyright